Risk of adverse events with the addition of targeted agents to endocrine therapy in patients with hormone receptor-positive metastatic breast cancer: A systematic review and meta-analysis.
暂无分享,去创建一个
M. Ceppi | E. de Azambuja | N. Pondé | M. Lambertini | L. Del Mastro | M. Bruzzone | C. Prady | A. Ferreira | Giulia Viglietti | C. Maurer | S. Martel